The Global Dalbavancin Market is an advanced, long-acting lipoglycopeptide antibiotic that is gaining strong traction worldwide as healthcare systems intensify their focus on effective, convenient therapies for serious Gram-positive infections, particularly skin and soft tissue infections. The emerging dalbavancin market is evolving rapidly on the back of rising antimicrobial resistance,...